| Style | Citing Format |
|---|---|
| MLA | Nili A, et al.. "Rituximab Monotherapy in Mild Pemphigus." Journal of Dermatological Treatment, vol. 33, no. 3, 2022, pp. 1784-1786. |
| APA | Nili A, Mahmoudi H, Heidari N, Tavakolpour S, Salehi Farid A, Balighi K, Daneshpazhooh M (2022). Rituximab Monotherapy in Mild Pemphigus. Journal of Dermatological Treatment, 33(3), 1784-1786. |
| Chicago | Nili A, Mahmoudi H, Heidari N, Tavakolpour S, Salehi Farid A, Balighi K, Daneshpazhooh M. "Rituximab Monotherapy in Mild Pemphigus." Journal of Dermatological Treatment 33, no. 3 (2022): 1784-1786. |
| Harvard | Nili A et al. (2022) 'Rituximab Monotherapy in Mild Pemphigus', Journal of Dermatological Treatment, 33(3), pp. 1784-1786. |
| Vancouver | Nili A, Mahmoudi H, Heidari N, Tavakolpour S, Salehi Farid A, Balighi K, et al.. Rituximab Monotherapy in Mild Pemphigus. Journal of Dermatological Treatment. 2022;33(3):1784-1786. |
| BibTex | @article{ author = {Nili A and Mahmoudi H and Heidari N and Tavakolpour S and Salehi Farid A and Balighi K and Daneshpazhooh M}, title = {Rituximab Monotherapy in Mild Pemphigus}, journal = {Journal of Dermatological Treatment}, volume = {33}, number = {3}, pages = {1784-1786}, year = {2022} } |
| RIS | TY - JOUR AU - Nili A AU - Mahmoudi H AU - Heidari N AU - Tavakolpour S AU - Salehi Farid A AU - Balighi K AU - Daneshpazhooh M TI - Rituximab Monotherapy in Mild Pemphigus JO - Journal of Dermatological Treatment VL - 33 IS - 3 SP - 1784 EP - 1786 PY - 2022 ER - |